+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Syndax Pharmaceuticals Inc - logo
Global Ovarian Cancer Drugs Market by Therapeutics Class (Angiogenesis Inhibitors, PARP Inhibitors, PD-L1 Inhibitors), Modality (Chemotherapy, Hormonal Therapy, Targeted Therapy), Drugs - Forecast 2023-2030 - Product Thumbnail Image

Global Ovarian Cancer Drugs Market by Therapeutics Class (Angiogenesis Inhibitors, PARP Inhibitors, PD-L1 Inhibitors), Modality (Chemotherapy, Hormonal Therapy, Targeted Therapy), Drugs - Forecast 2023-2030

  • Report
  • October 2023
  • 191 Pages
  • Global
From
Graft Versus Host Disease (GvHD) Treatment Market Forecast - Epidemiology & Pipeline Analysis 2022-2027 - Product Thumbnail Image

Graft Versus Host Disease (GvHD) Treatment Market Forecast - Epidemiology & Pipeline Analysis 2022-2027

  • Report
  • May 2022
  • 190 Pages
  • Global
From
Ovarian Cancer Drugs Global Market Report 2023 - Product Thumbnail Image

Ovarian Cancer Drugs Global Market Report 2023

  • Report
  • February 2023
  • 175 Pages
  • Global
From
Histone Deacetylase 3 (SMAP45 or RPD3 2 or HDAC3 or EC 3.5.1.98) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Histone Deacetylase 3 (SMAP45 or RPD3 2 or HDAC3 or EC 3.5.1.98) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • August 2022
  • 116 Pages
  • Global
From
Breast Cancer Diagnostic and Drug Technologies: Global Markets - Product Thumbnail Image

Breast Cancer Diagnostic and Drug Technologies: Global Markets

  • Report
  • November 2019
  • 150 Pages
  • Global
From
Acute Myeloid Leukemia (AML) Market Opportunity Assessment, Epidemiology, Clinical Trials, Unmet Needs and Forecast to 2032 - Product Thumbnail Image

Acute Myeloid Leukemia (AML) Market Opportunity Assessment, Epidemiology, Clinical Trials, Unmet Needs and Forecast to 2032

  • Report
  • September 2023
  • 79 Pages
  • Global
From
Fallopian tube cancer - Pipeline Insight, 2022 - Product Thumbnail Image

Fallopian tube cancer - Pipeline Insight, 2022

  • Clinical Trials
  • February 2022
  • 120 Pages
  • Global
From
Breast Cancer Therapeutics Drug Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Breast Cancer Therapeutics Drug Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • September 2023
  • 120 Pages
  • Global
From
CAR-T Cell Therapies: Intellectual Property Landscape (Featuring Historical and Contemporary Patent Filing Trends, Prior Art Search Expressions, Patent Valuation Analysis, Patentability, Freedom to Operate, Pockets of Innovation, Existing White Spaces, and Claims Analysis) - Product Thumbnail Image

CAR-T Cell Therapies: Intellectual Property Landscape (Featuring Historical and Contemporary Patent Filing Trends, Prior Art Search Expressions, Patent Valuation Analysis, Patentability, Freedom to Operate, Pockets of Innovation, Existing White Spaces, and Claims Analysis)

  • Report
  • April 2022
  • 116 Pages
  • Global
From
Graft versus host disease (GVHD) - Pipeline Insight, 2022 - Product Thumbnail Image

Graft versus host disease (GVHD) - Pipeline Insight, 2022

  • Drug Pipelines
  • July 2022
  • 160 Pages
  • Global
From
Graft Versus Host Disease (GvHD) - Market Insight, Epidemiology and Market Forecast -2032 - Product Thumbnail Image

Graft Versus Host Disease (GvHD) - Market Insight, Epidemiology and Market Forecast -2032

  • Report
  • January 2022
  • 200 Pages
  • Global
From
Bile Duct Cancer (Cholangiocarcinoma) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Bile Duct Cancer (Cholangiocarcinoma) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • December 2022
  • 507 Pages
  • Global
From
Global HDAC Inhibitors Market 2023-2027 - Product Thumbnail Image

Global HDAC Inhibitors Market 2023-2027

  • Report
  • January 2023
  • 157 Pages
  • Global
From
Graft Versus Host Disease (GVHD) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Graft Versus Host Disease (GVHD) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • June 2022
  • 636 Pages
  • Global
From
Histone Deacetylase 3 (SMAP45 or RPD3 2 or HDAC3 or EC 3.5.1.98) - Pipeline Review, H2 2018 - Product Thumbnail Image

Histone Deacetylase 3 (SMAP45 or RPD3 2 or HDAC3 or EC 3.5.1.98) - Pipeline Review, H2 2018

  • Drug Pipelines
  • September 2018
  • 96 Pages
  • Global
From
New Frontiers in Cancer Therapies: Focus on Transcription Factors, GTPases, Phosphatases and GPCRs, 2018-2030 - Product Thumbnail Image

New Frontiers in Cancer Therapies: Focus on Transcription Factors, GTPases, Phosphatases and GPCRs, 2018-2030

  • Report
  • May 2018
  • 200 Pages
  • Global
From
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • December 2022
  • 1560 Pages
  • Global
From
Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • April 2022
  • 527 Pages
  • Global
From
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • October 2022
  • 820 Pages
  • Global
From
HER2-Negative Breast Cancer: Global Drug Forecast and Market Analysis to 2028 - Product Thumbnail Image

HER2-Negative Breast Cancer: Global Drug Forecast and Market Analysis to 2028

  • Report
  • February 2020
  • 173 Pages
  • Global
From
Loading Indicator